X4 Pharmaceuticals, Inc — Director's Dealing 2021

Sep 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: X4 Pharmaceuticals, Inc (XFOR)
CIK: 0001501697
Period of Report: 2021-09-08

Reporting Person: DiBiase Mary (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-08	Common Stock	A	27000	—	Acquired	90444	Direct

Footnotes

F1: Represents restricted stock units issued to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer and has no expiration date. One third of the shares will vest on each of September 8, 2022, September 8, 2023 and September 8, 2024, respectively, subject to the Reporting Person providing continuous service to the Issuer on such dates.